This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Knight Therapeutics Inc.
Today reported financial results for its fourth quarter ended December 31, 2025. Revenues were $450,088, an increase of $78,784 or 21% over the prior year. Net loss was $5,374, compared to a net income of $4,332 in prior year.. Knight Therapeutics Inc. shares T.GUD are trading up $0.05 at $6.22.
